Fulcrum Therapeutics
FULC
#6784
Rank
A$0.90 B
Marketcap
A$13.79
Share price
-3.54%
Change (1 day)
121.64%
Change (1 year)

EPS for Fulcrum Therapeutics (FULC)

EPS in 2025 (TTM): A-$1.84

According to Fulcrum Therapeutics's latest financial reports the company's current EPS (TTM) is A-$1.70. In 2024 the company made an earnings per share (EPS) of A-$0.29 an increase over its 2023 EPS that were of A-$2.28.

EPS history for Fulcrum Therapeutics from 2019 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$1.84537.79%
2024A-$0.29-87.34%
2023A-$2.28-36.29%
2022A-$3.588.3%
2021A-$3.31-18.51%
2020A-$4.06-31.36%
2019A-$5.91

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
A-$2.50 46.61%๐Ÿ‡บ๐Ÿ‡ธ USA